LOS ANGELES, Sept. 27, 2024 /PRNewswire/ -- Gundry MD ® is thrilled to announce the 5th anniversary of its revolutionary gut health supplement, Bio Complete 3™. This product has set a new ...

Bio-Rad Laboratories, Inc. BIO is scheduled to release third-quarter 2024 results on Oct. 30, after the closing bell. The ...

Bio-Techne Corporation TECH is set to release its first-quarter fiscal 2025 results on Oct. 30, before the opening bell. The ...

Nuvation Bio's Taletrectinib shows promising data in phase 2 trials for ROS1-positive NSCLC. Find out my recommendation on ...

Mizuho Securities analyst Salim Syed has maintained their bullish stance on BBIO stock, giving a Buy rating on October 9. Salim Syed has given ...

ImmunityBio's ANKTIVA shows strong progress in NSCLC and endometrial cancer. Learn more about IBRX stock and potential buy ...

If you’re looking for a big-ticket item, a bike is probably top of the list for a lot of seven-year-olds. This bike has been ...

The Hong Kong market has seen a significant boost recently, driven by China's robust stimulus measures aimed at revitalizing its economy. This positive sentiment has also lifted the Hang Seng Index, ...

Diversified Trust Co grew its holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 3.0% during the 3rd quarter, ...

Over the past five years, Gundry MD Bio Complete 3 has transformed how people approach digestive health, making it easier than ever to combat common gut health issues.†* Continue Reading Gundry ...

Bio-Rad Laboratories, Inc. BIO is scheduled to release third-quarter 2024 results on Oct. 30, after the closing bell. The company posted adjusted earnings per share (EPS) of $3.11 in the last ...